Harvard Bioscience Inc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 85.77M108.18M108.86M111.17M105.17M108.66M108.66M104.52M77.41M120.77M116.18M102.10M118.90M113.33M112.25M94.14M
Cost of Revenue 44.09M56.37M58.67M58.83M57.48M59.32M59.94M56.11M38.24M57.59M51.85M44.06M51.25M52.52M46.18M39.37M
Gross Profit 41.68M51.81M50.19M52.34M47.70M49.34M48.72M48.41M39.17M63.18M64.32M58.04M67.65M60.82M66.07M54.77M
Operating items
Amortization - Intangibles 1.84M2.36M2.75M2.75M2.59M2.58M2.82M2.72M1.55M5.38M5.75M5.71M5.84M6.12M5.53M5.25M
Research & Development 4.40M4.67M3.87M4.34M4.15M4.88M6.42M5.39M5.64M10.99M10.71M8.69M10.80M12.33M11.76M10.41M
Selling, General & Administrative 15.11M17.67M17.63M18.12M17.89M16.83M19.83M20.95M17.52M21.38M22.76M23.51M24.30M24.49M22.76M21.49M
Restructuring Costs 0.52M0.50M0.47M0.31M2.15M1.03M0.79M-0.00M0.44M-0.23M
Other Operating Expenses 2.60M0.43M19.82M21.73M21.97M0.81M23.40M1.19M-8.45M3.61M30.47M25.63M30.48M31.16M29.66M29.08M
Operating Expenses 33.63M41.59M41.79M44.51M46.16M42.73M50.44M51.41M39.80M62.20M63.95M57.82M65.59M67.75M64.18M60.98M
Operating Income 8.05M10.22M8.40M7.83M1.54M6.62M-1.71M-3.00M-0.89M-1.67M-1.16M-1.53M2.07M-6.93M1.89M-6.21M
EBIT 8.05M10.22M8.40M7.83M1.54M6.62M-1.71M-3.00M-0.89M-1.67M-1.16M-1.53M2.07M-6.93M1.89M-6.21M
Non-operating items
Interest & Investment Income -0.28M-0.68M-5.37M-5.41M-4.83M-1.54M-2.55M-3.59M-3.21M
Other Non Operating Income -0.30M-0.38M-0.81M-0.29M-0.14M-1.14M-1.26M0.74M-0.74M-3.59M-0.47M-1.88M-0.67M0.30M-0.23M-0.65M
Non Operating Income 1.76M-0.66M-1.54M-0.94M-1.10M-2.20M-1.90M-0.18M-1.99M-8.96M-5.88M-7.51M-2.21M-2.25M-4.45M-5.45M
Net income details
EBT 9.81M9.56M6.87M6.89M2.98M4.42M-3.61M-3.11M-3.66M-9.03M-5.62M-7.29M-0.14M-9.18M-2.56M-11.66M
Tax Provisions 2.67M-9.45M1.58M2.40M0.46M2.06M15.43M1.23M-0.60M-3.68M-0.81M0.66M0.52M0.83M0.86M0.74M
Profit After Tax 7.23M19.02M5.29M4.49M-1.83M2.35M-19.04M-4.31M-2.02M-4.30M-4.69M-7.81M-0.29M-9.52M-3.42M-12.40M
Equity Income -0.63M-1.59M
Income from Continuing Operations 7.14M19.02M5.29M4.49M2.52M2.35M-19.04M-4.34M-3.06M-5.36M-4.80M-7.95M-0.66M-10.01M-3.42M-12.40M
Consolidated Net Income 0.09M19.02M-1.48M-2.12M-2.55M2.35M-19.04M-4.34M1.15M1.38M-4.80M-7.95M-0.66M-10.01M-3.42M-12.40M
Income towards Parent Company 0.09M19.02M-1.48M-2.12M-2.55M2.35M-19.04M-4.34M1.15M1.38M-4.80M-7.95M-0.66M-10.01M-3.42M-12.40M
Net Income towards Common Stockholders 0.09M19.02M-1.48M-2.12M-2.55M2.35M-19.04M-4.34M1.15M1.38M-4.80M-7.95M-0.66M-10.01M-3.42M-12.40M
Additional items
EPS (Basic) 0.240.660.190.16-0.060.07-0.57-0.13-0.06-0.12-0.12-0.20-0.01-0.23-0.08-0.28
EPS (Weighted Average and Diluted) 0.240.650.180.15-0.060.07-0.57-0.13-0.06-0.12-0.12
Shares Outstanding (Weighted Average) 29.47M28.29M28.50M28.82M31.01M32.42M33.94M34.37M34.88M37.29M38.07M38.98M40.81M41.66M42.69M43.62M
Shares Outstanding (Diluted Average) 29.95M29.40M29.82M29.79M31.91M33.24M33.59M34.21M34.75M36.45M
EBITDA 8.05M10.22M8.40M7.83M1.54M6.62M-1.71M-3.00M-0.89M-1.67M-1.16M-1.53M2.07M-6.93M1.89M-6.21M
Interest Expenses 0.28M0.68M0.75M0.58M0.95M0.99M0.85M0.64M0.71M5.37M
Tax Rate 27.24%22.99%34.79%15.42%46.68%16.52%40.69%14.51%